The Global Fund for HIV, TB, and Malaria has reaffirmed its commitment to rolling out the twice-yearly HIV prevention jab, lenacapavir, in lower-income countries, including South Africa. This initiative will continue with or without the support of the US President’s Emergency Plan for AIDS Relief (Pepfar), which recently encountered funding disruptions during President Donald Trump’s term. According to Global Fund…